Moreover, loss of CDO1 accelerated proliferation via restraining the generation of the toxic intermediate product sulfite (SO32-) in non-small cell lung cancer (NSCLC) cells with constitutively activated NRF2 [19]. Here, CDO1 is linked to non-small cell lung carcinoma.